title: Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha.
abstract: To clarify specific mechanisms underlying cholesteatoma-induced bone destruction, surgical specimens of middle ear inflammatory granulation tissue with or without cholesteatoma were maintained in vitro and the bone-resorbing activity in their culture supernatants was analyzed by means of calcium release from mouse calvaria. Almost the same levels of bone-resorbing activity and prostaglandin (PG) E2 were found in the supernatants of both types of tissue. By contrast, aural polyp tissue yielded hardly any such activity or PGE2. Under the influence of indomethacin, however, only tissue with cholesteatoma produced considerable bone resorption activity, whereas PGE2 production was suppressed completely. Such activity in the cholesteatoma culture supernatant was not due to contamination of endotoxin and proved to be blocked by the introduction of anti-interleukin (IL)-1 alpha antibody into the calvarial assay system. Anti-IL-1 beta antibody had no effect on such activity. Interleukin-1 alpha was detected only in cholesteatoma tissue culture supernatants by means of enzyme-linked immunosorbent assay and by bioassay. These data suggest that the bone destruction in otitis media with cholesteatoma may be attributed to IL-1 alpha in addition to PGE2.
authors.affiliation: Department of Otolaryngology, Tohoku University School of Medicine, Sendai, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Kurihara
authors.forename: M
authors.initials: M
authors.lastname: Toshima
authors.forename: R
authors.initials: R
authors.lastname: Yuasa
authors.forename: T
authors.initials: T
authors.lastname: Takasaka
mesh_terms: D000818:Animals; D001862:Bone Resorption / Q000209:etiology*; D002781:Cholesteatoma / Q000150:complications / Q000378:metabolism*; D046508:Culture Techniques; D015232:Dinoprostone / Q000378:metabolism*; D004427:Ear Diseases / Q000150:complications / Q000378:metabolism*; D006097:Granulation Tissue / Q000378:metabolism; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism*; D051379:Mice; D010033:Otitis Media / Q000150:complications / Q000378:metabolism*; D012886:Skull / Q000473:pathology
chemical_list: D007375:Interleukin-1; D015232:Dinoprostone